EU approves non-renewal of active substance benfluralin
Please submit your representation on the matter
Google にログインすると作業内容を保存できます。詳細
メールアドレス *
Name of the contact person *
Designation of the contact person *
Name of the company *
Email id *
Telephone(with STD code)/Mobile Number *
Name of the products exported with ITC-HS *
Will the stated measure upon implementation affect market access of your products ? *
If yes, what are your justification against the stated measure ? *
Please provide statistical figures, reference to documents substantiating your justification to the item at 7) above. *
Is it possible to comply with the measures ? *
What is the estimated expenditure to comply with the measures ? (values in US$ million) *
How much of your exports will get affected by implementation of this measure ? (values in US$ million) *
送信
フォームをクリア
Google フォームでパスワードを送信しないでください。
reCAPTCHA
プライバシー利用規約
このコンテンツは Google が作成または承認したものではありません。 不正行為の報告 - 利用規約 - プライバシー ポリシー
Google フォーム